Radiotherapy and immunology
Journal of Experimental Medicine · 01.07.2024 · 221 (7)
DOI: 10.1084/jem.20232101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Experimental Medicine, online erschienen am 21.05.2024. Verfasst von Liangliang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Radiotherapy. Die Arbeit wurde bisher 133-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Chicago Tumor Institute, NCI NIH HHS.
Abstract (Originalsprache)
The majority of cancer patients receive radiotherapy during the course of treatment, delivered with curative intent for local tumor control or as part of a multimodality regimen aimed at eliminating distant metastasis. A major focus of research has been DNA damage; however, in the past two decades, emphasis has shifted to the important role the immune system plays in radiotherapy-induced anti-tumor effects. Radiotherapy reprograms the tumor microenvironment, triggering DNA and RNA sensing cascades that activate innate immunity and ultimately enhance adaptive immunity. In opposition, radiotherapy also induces suppression of anti-tumor immunity, including recruitment of regulatory T cells, myeloid-derived suppressor cells, and suppressive macrophages. The balance of pro- and anti-tumor immunity is regulated in part by radiotherapy-induced chemokines and cytokines. Microbiota can also influence radiotherapy outcomes and is under clinical investigation. Blockade of the PD-1/PD-L1 axis and CTLA-4 has been extensively investigated in combination with radiotherapy; we include a review of clinical trials involving inhibition of these immune checkpoints and radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
- Ludwig Center for Metastasis Research, University of Chicago , Chicago, IL, USA.
- Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Liangliang Wang, Connor Lynch, Sean P Pitroda, András Piffkó, Kaiting Yang, Amy K Huser, Hua Laura Liang, Ralph R Weichselbaum
Förderung
- German Research Foundation
- Chicago Tumor Institute
- NCI NIH HHS
- Ludwig Cancer Research
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wang, L., Lynch, C., Pitroda, S. P., Piffkó, A., Yang, K., Huser, A. K., Liang, H. L., & Weichselbaum, R. R. (2024). Radiotherapy and immunology. Journal of Experimental Medicine, 221(7). https://doi.org/10.1084/jem.20232101
Vancouver
Wang L, Lynch C, Pitroda SP, Piffkó A, Yang K, Huser AK, et al. Radiotherapy and immunology. Journal of Experimental Medicine. 2024;221(7). doi:10.1084/jem.20232101
BibTeX
@article{Wang2024,
author = {Wang, Liangliang and Lynch, Connor and Pitroda, Sean P and Piffkó, András and Yang, Kaiting and Huser, Amy K and Liang, Hua Laura and Weichselbaum, Ralph R},
title = {Radiotherapy and immunology},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {7},
doi = {10.1084/jem.20232101}
}
EUVIMED